For centuries, scientists have thought of the brain as a single, unified organ. But new research led by Stanford Medicine reveals that what we call the brain is two distinct organs that evolved independently over hundreds ...
3 hours ago
0
0
"I think you always believe it's never going to happen to me." That is how one parent described learning that their newborn baby had been identified as being at possible risk of a rare genetic condition through routine newborn ...
Jul 15, 2026
0
4
Digging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have discovered why nerve cells overfire in the disease. Not only that—they have also designed a new ...
Jun 28, 2026
0
18
The race to complete the human pangenome—which comprises all genetic information across the human species—has been underway since 2022, when the first complete reference human genome sequence was released by the international ...
Jun 10, 2026
0
7
A lightweight robotic device that facilitates neuromuscular recovery in children with spinal muscular atrophy (SMA), helping them to stand unassisted, is published in Nature this week. Improved function persists after discontinuing ...
May 21, 2026
0
6
New Zealand does not have enough neurologists to keep up with the increase in demand for the diagnosis and treatment of conditions such as multiple sclerosis, Alzheimer's disease and stroke, research from the University of ...
Feb 19, 2026
0
22
A positive newborn screening for spinal muscular atrophy (SMA) is currently considered a medical emergency. Without early treatment, severe disability or death in infancy are likely. However, research findings from Germany ...
Feb 13, 2026
0
20
The tiny zebrafish is helping researchers rapidly determine whether a newborn's genetic mutation is likely to cause spinal muscular atrophy (SMA), one of the leading causes of infant mortality worldwide. The world-first research, ...
Jan 28, 2026
0
10
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the disease. Potential treatments typically target a key mutated oncogene called KRAS. In some cases, PDAC ...
Jan 8, 2026
0
36
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...
Dec 8, 2025
0
12
